RJA
CRDF icon

Raymond James & Associates’s Cardiff Oncology CRDF Stock Holding History

Raymond James & Associates’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-306
Closed -$8K – 3601
2018
Q1 		$8K Sell
306
-13
-4% -$320 ﹤0.01% 3414
2017
Q4 		$7K Hold
319
– – ﹤0.01% 3387
2017
Q3 		$17K Sell
319
-14
-4% -$873 ﹤0.01% 3326
2017
Q2 		$30K Sell
333
-14
-4% -$902 ﹤0.01% 3221
2017
Q1 		$29K Buy
347
+28
+9% +$3.8K ﹤0.01% 3184
2016
Q4 		$48K Buy
319
+171
+116% +$39.9K ﹤0.01% 3098
2016
Q3 		$48K Buy
+148
New +$54K ﹤0.01% 3081

Other funds holding CRDF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return